Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - AccuredReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kura Oncology (KURA) Non-Current Assets (2024 - 2025)

Historic Non-Current Assets for Kura Oncology (KURA) over the last 2 years, with Q3 2025 value amounting to $28.7 million.

  • Kura Oncology's Non-Current Assets rose 8352.51% to $28.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $86.0 million, marking a year-over-year change of. This contributed to the annual value of $15.3 million for FY2024, which is N/A changed from last year.
  • As of Q3 2025, Kura Oncology's Non-Current Assets stood at $28.7 million, which was up 8352.51% from $22.3 million recorded in Q2 2025.
  • In the past 5 years, Kura Oncology's Non-Current Assets ranged from a high of $28.7 million in Q3 2025 and a low of $15.3 million during Q4 2024